(Total Views: 485)
Posted On: 09/08/2019 7:50:43 AM
Post# of 154006
Dr. Sasha probably will talk about the half-life modification also.
For ViiV, Shionogi joined in 2012. NP mentioned a Japanese company they talked with I believe at some point, probably them.
From wiki,
In 2012 Shionogi joined the company. 76.5% of the company is now owned by GlaxoSmithKline, 13.5% by Pfizer and 10% by Shionogi.[2] This ownership structure may change depending upon the achievement of certain milestones.[1]
ViiV Healthcare's products have a market share of approximately 19%[3] of the global HIV market, which makes it the second largest healthcare company, following after Gilead Sciences, that is working on the treatment of HIV.[4]
For ViiV, Shionogi joined in 2012. NP mentioned a Japanese company they talked with I believe at some point, probably them.
From wiki,
In 2012 Shionogi joined the company. 76.5% of the company is now owned by GlaxoSmithKline, 13.5% by Pfizer and 10% by Shionogi.[2] This ownership structure may change depending upon the achievement of certain milestones.[1]
ViiV Healthcare's products have a market share of approximately 19%[3] of the global HIV market, which makes it the second largest healthcare company, following after Gilead Sciences, that is working on the treatment of HIV.[4]
(1)
(0)
